Primary Brain Tumor Clinical Trials

8 recruiting

Primary Brain Tumor Trials at a Glance

9 actively recruiting trials for primary brain tumor are listed on ClinicalTrialsFinder across 6 cities in 4 countries. The largest study group is Not Applicable with 3 trials, with the heaviest enrollment activity in Atlanta, Augusta, and Dresden. Lead sponsors running primary brain tumor studies include Jona Hattangadi-Gluth, Memorial Sloan Kettering Cancer Center, and Dartmouth-Hitchcock Medical Center.

Browse primary brain tumor trials by phase

Treatments under study

About Primary Brain Tumor Clinical Trials

Looking for clinical trials for Primary Brain Tumor? There are currently 8 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Primary Brain Tumor trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Primary Brain Tumor clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 19 of 9 trials

Recruiting
Not Applicable

Non-invasive Glioma Characterization Through Molecular Imaging

Brain TumorGliomaPrimary Brain Tumor+2 more
University of Miami30 enrolled1 locationNCT03684109
Recruiting
Phase 1

A Study of Avutometinib for People With Solid Tumor Cancers

Solid TumorSolid Tumor, AdultNeuroblastoma+12 more
Memorial Sloan Kettering Cancer Center23 enrolled2 locationsNCT06104488
Recruiting

Assessment of Eloquent Function in Brain Tumor Patients

Metastatic Brain TumorPrimary Brain Tumor
University of Nebraska75 enrolled1 locationNCT01535430
Recruiting
Phase 1

Chemo-immunotherapy Using Ibrutinib Plus Indoximod for Patients With Pediatric Brain Cancer

GlioblastomaPrimary Brain TumorMedulloblastoma+1 more
Theodore S. Johnson37 enrolled1 locationNCT05106296
Recruiting
Not Applicable

HOBSCOTCH-CA (HOme-Based Self-management and COgnitive Training CHanges Lives in Brain CAncer)

Brain NeoplasmsBrain TumorCognitive Dysfunction+9 more
Dartmouth-Hitchcock Medical Center125 enrolled1 locationNCT06930846
Recruiting
Not Applicable

Proton Versus Photon Radiotherapy in Adults With Primary Brain Tumors

MeningiomaDiffuse GliomaPituitary Adenoma+2 more
Tata Memorial Centre156 enrolled1 locationNCT06831461
Recruiting

Neurocognitive Function After Proton Therapy in Children and Adolescents

Primary Brain Tumor
Technische Universität Dresden90 enrolled3 locationsNCT04066465
Recruiting

Longitudinal Prospective Study of Neurocognition & Neuroimaging in Primary BT Patients

MeningiomaGliomaPrimary Brain Tumor+1 more
Jona Hattangadi-Gluth250 enrolled1 locationNCT05576103
Recruiting

Biobank and Register of Patients With Agresive Tumors for Translational and Analytical Research

Soft Tissue SarcomaMelanomaMalignant Solid Tumors+1 more
N.N. Petrov National Medical Research Center of Oncology1,000 enrolled1 locationNCT05539677